Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on June 23, 2026

an hour ago

Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia

Indeterminate GlobeNewswire

an hour ago

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

Indeterminate GlobeNewswire

an hour ago

Integra LifeSciences Announces Key Executive Appointments

Indeterminate GlobeNewswire

an hour ago

Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors

Indeterminate GlobeNewswire

an hour ago

Kalaris Announces Upcoming Presentation of TH103 Phase 1a Clinical Data at American Society of Retina Specialists; Ph 1b/2 Clinical Trial Actively Enrolling

Indeterminate GlobeNewswire

an hour ago

Ichnos Glenmark Innovation (IGI) Announces Appointment of Mariana Cota Stirner, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

an hour ago

Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

Indeterminate GlobeNewswire

an hour ago

Corxel Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Trial of CX11 in Obese and Overweight U.S. Adults

Indeterminate GlobeNewswire

an hour ago

IMUNON Announces Data Monitoring Committee Recommends Continuation of Phase 3 OVATION 3 Study Without Modification

Indeterminate GlobeNewswire

an hour ago

Solenic Medical® Receives FDA IDE Approval to Initiate Pivotal Trial of SOLA-2™ for Periprosthetic Joint Infections

Indeterminate GlobeNewswire

an hour ago

INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB

Indeterminate GlobeNewswire

an hour ago

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Indeterminate GlobeNewswire

an hour ago

Revolution Medicines Begins Treating Patients in RASolute 305, a Phase 3 Clinical Trial Evaluating Zoldonrasib in Combination with Chemotherapy as a First Line Treatment for Patients with RAS G12D Metastatic Pancreatic Cancer 

Indeterminate GlobeNewswire

an hour ago

Persephone Biosciences’ Science-Backed Infant and Toddler Synbiotics Now Available on Amazon

Indeterminate GlobeNewswire

an hour ago

Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)

Indeterminate GlobeNewswire

an hour ago

Entact Bio Appoints John G. Houston, Ph.D., to its Board of Directors

Indeterminate GlobeNewswire

an hour ago

Boundless Bio and Serapha Bio Announce Merger Agreement and $230 Million Concurrent Private Placement

Indeterminate GlobeNewswire

an hour ago

Zevra Therapeutics Announces Publication of Positive MIPLYFFA® Data from Pediatric Substudy in Infants with Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

an hour ago

Plus Therapeutics to Provide Business Update Call on June 30, 2026

Indeterminate GlobeNewswire

an hour ago

Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

Indeterminate GlobeNewswire